Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase EARLY_PHASE1 1Phase 1 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Conditions

Unspecified Adult Solid Tumor, Protocol Specific 1Triple Negative Breast Neoplasms 1Somatostatinoma 1Pheochromocytoma 1Neurofibrosarcoma 1Neurofibromatosis 1 1Myeloproliferative Disorders 1Myelodysplastic-Myeloproliferative Diseases 1Melanoma 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1Kidney Neoplasms 1Insulinoma 1Glucagonoma 1Gastrinoma 1Fibrosis 1Carcinoma, Renal Cell 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Merkel Cell 1Carcinoma, Medullary 1Carcinoma, Islet Cell 1Anatomic Stage II Breast Cancer AJCC v8 1

Interventions

Magnetic Resonance Spectroscopy 2sonidegib 1navitoclax 1Vitamin D 1Specimen Handling 1Sorafenib 1Radiotherapy 1Radiation 1N1-(3-(dimethylamino)propyl)-N8-hydroxy-2-((naphthalene-1-loxy)methyl)oct-2-enediamide 1High-Energy Shock Waves 1Enkephalin, Methionine 1Biopsy 1ARQ 197 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Fibrosis × High-Energy Shock Waves × Clear all
NCT03278925 2024-08-02

Defined Green Tea Catechin Extract in Preventing Liver Cancer in Participants With Cirrhosis

National Cancer Institute (NCI)

Phase 1 Active not recruiting
14 enrolled

Fibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡